Boston Scientific 18. Mai 2026 Boston Scientific invests $1.5B in MiRus with option to buy its TAVR business - Cardiovascular Business
10x Genomics Blog 18. Mai 2026 The 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call - Yahoo! Finance Canada
10x Genomics News 18. Mai 2026 The 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call - Yahoo Finance
IQVIA 18. Mai 2026 From AI Pilots to Real Impact: Transforming Life Sciences Workflows with Agentic AI - IQVIA
Merck & Co. 18. Mai 2026 Merck ADC, licensed from China, hits mark in first big global trial - BioPharma Dive
Boston Scientific 18. Mai 2026 Boston Scientific buys $1.5B stake in TAVR developer MiRus - MedTech Dive
Thermo Fisher 18. Mai 2026 Thermo Fisher Scientific’s PPD Clinical Research Business Expands Bioanalytical Capabilities with Ne - PharmiWeb.com
FierceBiotech 18. Mai 2026 BioMarin’s $270M Inozyme bet looks in trouble after rare disease drug misses key ph. 3 goal